Learning Objectives:
1. Discuss CSF biomarkers for the early diagnosis and monitoring of disease progression in Parkinson's disease and atypical parkinsonism
2. Describe the role of tissue biomarkers in Parkinson’s disease, focusing on their biological significance and translational applications in clinical practice
3. Report advancements in blood-based biomarkers including -omics in parkinsonism and their role in enhancing diagnostic accuracy and monitoring disease progression